SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001047469-09-008048
Filing Date
2009-08-28
Accepted
2009-08-28 17:03:35
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B3 a2194398z424b3.htm 424B3 1846566
2 G120215.JPG g120215.jpg GRAPHIC 11527
3 G378074.JPG g378074.jpg GRAPHIC 17848
4 G825671.JPG g825671.jpg GRAPHIC 12325
5 G347176.JPG g347176.jpg GRAPHIC 3908
  Complete submission text file 0001047469-09-008048.txt   1911531
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-160257 | Film No.: 091043856
SIC: 2835 In Vitro & In Vivo Diagnostic Substances